The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study
Abstract
Mood stabilizers are used clinically for the management of bipolar disorder. Prophylactic therapy with mood stabilizers is the primary treatment for preventing depressive and manic relapses in bipolar patients once they are stabilized. In this study, we examined the relative efficacy of the three most commonly used mood-stabilizing agents: lithium (Li), valproic acid (VPA), and carbamazepine (CBZ), in preventing relapse episodes. A total of 225 patients with bipolar disorder were included in the present analysis. Patients taking Li, VPA, or CBZ were followed up for up to 124 months, until suffering a manic, mixed, or depressive episode (relapse), or until the end of the study/study termination (no relapse), whichever came first. The median unadjusted survival time was 36 months for patients taking VPA, 42 months for patients taking CBZ, and 81 months for patients taking Li. These results indicate that patients stayed longer on Li, suggesting that it might have been better tolerated than either CBZ or VPA. χ-Analysis showed that patients taking Li were significantly less likely to experience relapse during the observational period than patients taking either VPA or CBZ (P<0.05). A Cox regression model showed that the hazard of experiencing relapse was significantly predicted by the total number of depressive (P=0.007) and manic symptoms (P=0.02) assessed before the observation period. In addition, after controlling for symptom covariates, the hazard of experiencing relapse was 1.66 times (95% confidence interval 1.03-2.67) or 66% higher for patients taking VPA compared with patients taking Li (P=0.037). Although the hazard of experiencing relapse was higher for patients taking CBZ compared with those taking Li, the risk was not elevated by a significant amount. Notwithstanding the limitations of the naturalistic design of this study, the differences in relapse prevention and survival time observed in these medications show Li fairing relatively better in prophylactic therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patient cohorts followed in a specific setting provide another source of informative data. Their main advantage usually is the length of observation, in some instances reaching several decades.363, 364, 365”
Citations
Cites
Bowden, C. L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.481 · Cited by 678
Goodwin, G. M., Bowden, C. L., Calabrese, J. R., Grunze, H., Kasper, S., White, R., Greene, P., & Leadbetter, R. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0321 · Cited by 581 · cited 2×
“Following treatment of acute episodes, BD patients not taking any maintenance medications have been shown to have relapse rates of around 61%, leading to significant impairments in functioning and quality of life (Goodwin et al., 2004).”
BackgroundResultInfluentialComparative Prophylactic Efficacy of Lithium, Carbamazepine, and the Combination in Bipolar Disorder
Denicoff, K. D., Smith-Jackson, E. E., Disney, E. R., Ali, S. O., Leverich, G. S., & Post, R. M. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1102 · Cited by 311
The course of affective disorders: II. Typology of bipolar manic-depressive illness
Angst, J. (1978) · Archiv f�r Psychiatrie und Nervenkrankheiten Vereinigt mit Zeitschrift f�r die Gesamte Neurologie und Psychiatrie · doi:10.1007/bf00344125 · Cited by 310
Antidepressants for the Acute Treatment of Bipolar Depression: A Systematic Review and Meta-Analysis
Sidor, M. M., & MacQueen, G. M. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05385gre · Cited by 308
Vining, E. P. G., Mellits, E. D., Dorsen, M. M., Cataldo, M. F., Quaskey, S. A., Spielberg, S. P., & Freeman, J. M. (1987) · Pediatrics · doi:10.1542/peds.80.2.165 · Cited by 270
Lithium versus carbamazepine in the maintenance treatment of bipolar disorders – a randomised study
Greil, W., Ludwig-Mayerhofer, W., Erazo, N., Schöchlin, C., Schmidt, S., Engel, R. R., Czernik, A., Giedke, H., Müller-Oerlinghausen, B., Osterheider, M., et al. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(96)01427-9 · Cited by 261
Carbamazepine Compared With Lithium in the Treatment of Mania
Small, J. G. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810340047006 · Cited by 186
Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder
Coxhead, N., Silverstone, T., & Cookson, J. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb01453.x · Cited by 134
Research works printed but not linked: 3
- Culpepper, 2014, Prim Care Companion CNS Disord, 16, PCC.13r01609
- Lambert, 1966, Ann Med Psychol, 1, 707
- MacRitchie, 2001, Cochrane Database Syst Rev, 3, CD003196
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer
DAMASKOS, C., VALSAMI, S., KONTOS, M., SPARTALIS, E., KALAMPOKAS, T., KALAMPOKAS, E., ATHANASIOU, A., MORIS, D., DASKALOPOULOU, A., DAVAKIS, S., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11286 · Cited by 192
Nestsiarovich, A., Gaudiot, C., Baldessarini, R. J., Vieta, E., Zhu, Y., & Tohen, M. F. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.08.264 · Cited by 105
Efficacy of Carbamazepine and Its Derivatives in the Treatment of Bipolar Disorder
Grunze, A., Amann, B. L., & Grunze, H. (2021) · Medicina · doi:10.3390/medicina57050433 · Cited by 61
Liu, T., Hsieh, Y., Chou, C.-J., & Yang, P. (2018) · Royal Society Open Science · doi:10.1098/rsos.181321 · Cited by 60
Metadata
- Authors
- Peselow, E. D., Clevenger, S., & IsHak, W. W.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Corresponding author
- IsHak, Waguih W.
- Venue
- International Clinical Psychopharmacology
- Published
- 2016-07
- Volume
- 31
- Issue
- 4
- Pages
- 218-223
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2153764535
- Cited by
- 31
- References
- 26
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 2
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar disorder, mood stabilizers, lithium, valproic acid, carbamazepine, prophylaxis, relapse prevention, maintenance therapy, treatment tolerability, survival time
- MeSH terms
- Adult, Bipolar Disorder, Carbamazepine, Female, Follow-Up Studies, Humans, Lithium, Male, Middle Aged, Valproic Acid, Treatment Outcome, Antimanic Agents, Secondary Prevention, Post-Exposure Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study. https://app.cochat.ai/papers/10.1097/yic.0000000000000097
- The paper
- Peselow, E. D., Clevenger, S., & IsHak, W. W. (2016). Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0000000000000097
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.